test

Harold Schaaff

@Soleus Capital Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.

Assets under management

The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ORGOOrganogenesis Hldgs Inc
Recent Activity
Increased 2.79%
2.63%
$33.862M
11.84M shares@ $2.86 avg price
IDYAIdeaya Biosciences Inc
Recent Activity
Increased 51.19%
2.58%
$33.242M
1.049M shares@ $31.69 avg price
RVMDRevolution Medicines Inc
Recent Activity
Decreased -17.7%
2.48%
$31.953M
704,584 shares@ $45.35 avg price
QDELQuidelortho Corp
Recent Activity
New Position
2.43%
$31.282M
686,000 shares@ $45.6 avg price
EPIXEssa Pharma Inc
Recent Activity
Increased 1.85%
2.02%
$25.986M
4.288M shares@ $6.06 avg price
JSPRJasper Therapeutics Inc
Recent Activity
Increased 5.29%
1.96%
$25.274M
1.344M shares@ $18.82 avg price
SRDXSurmodics Inc
Recent Activity
Decreased -18.42%
1.92%
$24.73M
637,698 shares@ $38.78 avg price
NRIXNurix Therapeutics Inc
Recent Activity
Decreased -48.15%
1.86%
$23.949M
1.066M shares@ $22.48 avg price
TXG10x Genomics Inc
Recent Activity
Increased 32.27%
1.67%
$21.474M
951,000 shares@ $22.58 avg price
SNDXSyndax Pharmaceuticals Inc
Recent Activity
Increased 32.01%
1.63%
$21.001M
1.091M shares@ $19.25 avg price